ClassID:

115469

C12Y204/02012 - CPC Classification

Classification description:

Glycosyltransferases (2.4); Pentosyltransferases (2.4.2) Nicotinamide phosphoribosyltransferase (2.4.2.12), i.e. visfatin

Recent Application in this class:
#1
20260034213
2026-02-05

SYSTEMS AND METHODS FOR TARGETING NAD-BASED PATHWAYS FOR TREATMENT OF CANCER

#2
20250270607
2025-08-28

PROTEIN HAVING NAMPT ACTIVITY, AND METHOD FOR PRODUCING NMN

#3
20250257332
2025-08-14

TRUNCATED AND FUSION PROTEINS

#4
20240299505
2024-09-12

COMPOSITION FOR IMPROVING, PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING NAMPT-DERIVED PEPTIDE AS ACTIVE INGREDIENT

#5
20240085422
2024-03-14

BIOMARKERS AND METHODS OF USE FOR RADIATION-INDUCED LUNG INJURY

#6
20240043894
2024-02-08

PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES

#7
20230383329
2023-11-30

Adenosine-Involved Fully Enzymatic Synthesis Method for NMN

#8
20230332114
2023-10-19

MODIFIED NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE

#9
20230181466
2023-06-15

BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES

#10
20230022968
2023-01-26

Innovative method for improving enzyme activity of NMN biosynthetic enzyme nampt

#11
20220403412
2022-12-22

Baculovirus Of Recombinant Superoxide Dismutase Gene, Preparation And Application Thereof

#12
20220348931
2022-11-03

Innovative method for improving enzyme activity of NMN biosynthetic enzyme Nampt

#13
20220233443
2022-07-28

PRODUCTION AND USE OF EXTRACELLULAR VESICLE-CONTAINED ENAMPT

#14
20210371843
2021-12-02

Genetically engineered bacteria, its construction method and its application in producing NAD method

#15
20210322507
2021-10-21

GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS

#16
20210246476
2021-08-12

BIOSYNTHESIS OF PREPARING NICOTINAMIDE MONONUCLEOTIDE AND DERIVATIVES THEREOF

#17
20200405736
2020-12-31

Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity

#18
20200332332
2020-10-22

Method for Producing Nicotinamide Mononucleotide and Transformant Used in Said Method

#19
20200132689
2020-04-30

Biomarkers and methods of use for radiation-induced lung injury

#20
20190160139
2019-05-30

GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS

#21
20190153407
2019-05-23

Nicotinamide phosphoribosyltransferase (NAMPT) mutant and use thereof

#22
20190093140
2019-03-28

ENZYMATIC SYSTEMS AND METHODS FOR SYNTHESIZING NICOTINAMIDE MONONUCLEOTIDE AND NICOTINIC ACID MONONUCLEOTIDE

#23
20190071680
2019-03-07

MICROBIAL PRODUCTION OF NICOTINIC ACID RIBOSIDE

#24
20180338991
2018-11-29

NAD BIOSYNTHESIS AND PRECURSORS FOR THE TREATMENT AND PREVENTION OF CANCER AND PROLIFERATION

#25
20180230443
2018-08-16

Nicotinamide phosphoribosyltransferase (NAMPT) mutant and use thereof

#26
20180162895
2018-06-14

Method for preparing nicotinamide mononucleotide (NMN)

#27
20180125871
2018-05-10

Targeting NAD to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity

#28
20170202822
2017-07-20

METHODS AND COMPOSITIONS FOR ENHANCING CANCER THERAPY

#29
20160202262
2016-07-14

APTAMERS SCREENING METHOD BASED ON GRAPHENE WITHOUT TARGET IMMOBILIZATION AND THE APTAMERS OBTAINED FROM THE METHOD

#30
20160202259
2016-07-14

Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method

#31
20150313930
2015-11-05

NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation

#32
20150265642
2015-09-24

NAD BIOSYNTHESIS AND PRECURSORS IN THE PREVENTION AND TREATMENT OF INFLAMMATION

#33
20150065432
2015-03-05

Visfatin therapeutic agents for the treatment of acne and other conditions

#34
20120328526
2012-12-27

Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof

#35
20100215634
2010-08-26

VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS